MedPath

CERAVE

CERAVE

Approved
DIN Number

02410923

Drug Class

Human

Market Date

Jan 22, 2014

Company
HC

cerave canada

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02410923
AIG Number0554630001
Classification & Schedule
C
Drug Class
Human
S
Schedule
OTC
A
ATC Code
D02BA30 COMBINATIONS OF PROTECTIVES AGAINST UV-RADIATION
Product Specifications
Dosage FormLotion
Route of AdministrationTopical
AHFS Classification84:80.00
Health Canada Classification

ACTIVE INGREDIENTS (5)

HOMOSALATEActive
Strength: 10 % / W/W
Monograph: HOMOSALATE
MERADIMATEActive
Strength: 5 % / W/W
Monograph: MERADIMATE
OCTINOXATEActive
Strength: 5 % / W/W
Monograph: OCTINOXATE
OCTOCRYLENEActive
Strength: 2 % / W/W
Monograph: OCTOCRYLENE
ZINC OXIDEActive
Strength: 6.3 % / W/W
Monograph: ZINC OXIDE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.